Monoclonal antibody and a method thereof
US10000573B2 · kind B2 · utility
5Cited by
12References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 31, 2017 |
| Grant date | Jun 19, 2018 |
| Priority date | — |
| Expiry date | May 31, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a humanized IgG1 isotype anti-CD6 antibody (T1h) that binds to the Scavenger receptor cysteine-rich (SRCR) domain 1 (D1) of CD6 present on the surface of thymic epithelial cells, monocytes, activated T cells and a variety of other cells types.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.